A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP

Launched by FRENCH CARDIOLOGY SOCIETY · Feb 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new type of heart device called the AVEIR VR leadless pacemaker, which is designed to help people with heart rhythm problems. Unlike traditional pacemakers that require wires and a surgical pocket, the leadless version is implanted using a simpler procedure that can make recovery easier and more comfortable for patients. The trial aims to assess how safe and effective this device is for people in France who need a pacemaker.

To participate in the trial, you need to be at least 18 years old and have already received the AVEIR VR leadless pacemaker. Participants will be monitored to gather information on their health and how well the device works in real-life situations. The study is currently recruiting participants, and both men and women are welcome to join. If you're interested, it’s important to discuss this with your healthcare provider to see if you meet the eligibility criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient implanted with an AVEIR VR LP device and/or an AR LP device
• • Patient over 18 years old
• • Patient informed of the nature of the study, agrees to participate in the study
• Exclusion Criteria:
• • Patient under 18 years of age
• • Patient refusing to participate in the study